Agilent Technologies, Inc. (NYSE:A) CEO Michael R. Mcmullen sold 22,481 shares of Agilent Technologies stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $70.00, for a total transaction of $1,573,670.00. Following the completion of the sale, the chief executive officer now owns 327,882 shares in the company, valued at approximately $22,951,740. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of Agilent Technologies, Inc. (A) traded down $0.05 on Wednesday, hitting $69.91. 5,330,500 shares of the stock were exchanged, compared to its average volume of 1,852,493. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.22 and a quick ratio of 2.76. The stock has a market cap of $22,515.09, a P/E ratio of 29.52, a PEG ratio of 2.75 and a beta of 1.27. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $70.81.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.05. The business had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 17.34%. The business’s revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.59 EPS. equities analysts forecast that Agilent Technologies, Inc. will post 2.59 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be issued a dividend of $0.149 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a yield of 0.85%. The ex-dividend date of this dividend is Friday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is 25.24%.

ILLEGAL ACTIVITY NOTICE: This report was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://www.watchlistnews.com/agilent-technologies-inc-a-ceo-michael-r-mcmullen-sells-22481-shares-of-stock/1719827.html.

A number of large investors have recently bought and sold shares of the business. BlackRock Inc. increased its holdings in Agilent Technologies by 1.2% during the 2nd quarter. BlackRock Inc. now owns 23,392,338 shares of the medical research company’s stock valued at $1,387,400,000 after acquiring an additional 273,119 shares in the last quarter. Vanguard Group Inc. increased its holdings in Agilent Technologies by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 22,093,669 shares of the medical research company’s stock valued at $1,310,374,000 after acquiring an additional 637,698 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Agilent Technologies by 45.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock valued at $720,358,000 after acquiring an additional 3,779,099 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in Agilent Technologies by 1.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,721,557 shares of the medical research company’s stock valued at $339,346,000 after acquiring an additional 84,801 shares in the last quarter. Finally, American Century Companies Inc. boosted its stake in shares of Agilent Technologies by 5.5% during the 2nd quarter. American Century Companies Inc. now owns 4,582,086 shares of the medical research company’s stock worth $271,764,000 after purchasing an additional 238,522 shares during the last quarter.

Several equities research analysts recently weighed in on A shares. Robert W. Baird reaffirmed a “buy” rating and set a $70.00 target price on shares of Agilent Technologies in a research note on Friday, October 20th. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 target price on the stock in a research note on Tuesday, October 10th. Deutsche Bank AG set a $68.00 target price on shares of Agilent Technologies and gave the stock a “buy” rating in a research note on Wednesday, August 16th. BidaskClub downgraded shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a report on Wednesday, August 9th. Five analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $68.20.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.